Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20226 (
TATA-binding protein
)
1,297
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have shown previously that under specific conditions, a TATA box will mediate efficient in vitro transcription by RNA polymerase (pol) III in the absence of a PSE or other promoter elements. The reaction requires a HeLa cell phosphocellulose protein fraction, fraction B, which must be preincubated with the template DNA.
Fraction
B does not contain any detectable pol II type transcription factor IID (TFIID) activity. In this report, the relationship between fraction B and TFIID was further examined. Purified human
TATA-binding protein
(
TBP
) can substitute for fraction B to mediate TATA-dependent pol III transcription. Both
TBP
and fraction B prefer a reverse TATA box for pol III transcription, yet
TBP
bound to a reverse TATA box functions poorly for pol II transcription. Like TFIID, fraction B forms a template-committed complex with TATA-containing promoters.
TBP
, however, will not template commit for pol III transcription unless premixed with phosphocellulose fraction C.
TBP
-mediated pol III transcription is also more sensitive to the detergent Sarkosyl (N-lauroylsarcosine, Sigma) than is the fraction B reaction unless it is premixed with fraction C. Together, the data suggest that
TBP
can complex with a component of fraction C, and this complex is then functionally equivalent to fraction B. We propose that fraction B contains
TBP
in a complex with some other component(s) of the pol III transcription machinery and that this B complex
TBP
may be specific for pol III transcription.
...
PMID:TATA box-mediated in vitro transcription by RNA polymerase III. Evidence for TATA-binding protein in a polymerase III type complex. 767 50